Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma.
A 73-year-old white man with nodular basal cell carcinoma (nBCC) of the toe and interdigital tinea pedis was treated with imiquimod cream 5% once daily for 4 weeks and twice daily for 10 weeks. Results of a posttreatment potassium hydroxide (KOH) preparation and biopsy confirmed clearance of both tinea pedis and nBCC, respectively.
Stashower
Mitchell E
ME
Clinical Center of Northern Virginia, Fairfax, USA.
D000287:Administration, Topical; D000368:Aged; D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077271:Imiquimod; D008297:Male; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D014008:Tinea Pedis / Q000150:complications / Q000188:drug therapy*; D014034:Toes
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod